Debate on "dual pathway inhibition": Antiplatelet therapy in patients with peripheral atherosclerotic disease: old but gold?

被引：1
|
作者：
Spaccarotella, Carmen [1 ]
Simonetti, Fiorenzo [1 ]
Piccolo, Raffaele [1 ]
Esposito, Giovanni [1 ]
机构：
[1] Univ Napoli Federico II, Dipartimento Sci Biomed Avanzate, Via Pansini 5, I-80131 Naples, Italy
来源：
GIORNALE ITALIANO DI CARDIOLOGIA | 2023年 / 24卷 / 04期
关键词：
ANKLE BRACHIAL INDEX; CARDIOVASCULAR EVENTS; ARTERY-DISEASE; RISK; PREVENTION; ASPIRIN; CLOPIDOGREL; MORTALITY;
D O I：
10.1714/4035.40103
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：24S / 27S
页数：4
相关论文
共 50 条
  • [31] Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease
    Ritchie, James
    Green, Darren
    Alderson, Helen V.
    Chrysochou, Constantina
    Vassallo, Diana
    Sinha, Smeeta
    Kalra, Philip A.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2016, 10 (02) : 149 - 158
  • [32] Antiplatelet therapy in peripheral occlusive arterial disease
    Wong, Shen
    Appleberg, Michael
    Lewis, David R.
    ANZ JOURNAL OF SURGERY, 2006, 76 (05) : 364 - 372
  • [33] The role of antiplatelet therapy in patients with peripheral artery disease and lower extremity peripheral artery revascularization
    Banerjee, Subhash
    Sarode, Karan
    Vinas, Ariel
    Banerjee, Avantika
    Mohammad, Atif
    Brilakis, Emmanouil S.
    CURRENT OPINION IN CARDIOLOGY, 2015, 30 (05) : 525 - 535
  • [34] Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease
    Berger, Peter B.
    Bhatt, Deepak L.
    Fuster, Valentin
    Steg, P. Gabriel
    Fox, Keith A. A.
    Shao, Mingyuan
    Brennan, Danielle M.
    Hacke, Werner
    Montalescot, Gilles
    Steinhubl, Steven R.
    Topol, Eric J.
    CIRCULATION, 2010, 121 (23) : 2575 - 2583
  • [35] Dual Antiplatelet Therapy in Coronary Artery Disease
    Sharma, Raghav
    Kumar, Prathap
    Prashanth, S. P.
    Belagali, Yogesh
    CARDIOLOGY AND THERAPY, 2020, 9 (02) : 349 - 361
  • [36] Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?
    Sumaya, Wael
    Geisler, Tobias
    Kristensen, Steen D.
    Storey, Robert F.
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (10) : 1583 - 1589
  • [37] Role of the laboratory in monitoring patients receiving dual antiplatelet therapy
    Vidali, M.
    Rolla, R.
    Parrella, M.
    Cassani, C.
    Manzini, M.
    Portalupi, M. R.
    Serino, R.
    Prando, M. D.
    Bellomo, G.
    Pergolini, P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 (05) : 484 - 494
  • [38] Study on the characteristic of intestinal flora in patients with dual antiplatelet therapy
    Chao, Guanqun
    Ye, Fangxu
    Shen, Wei
    Gong, Wenqian
    Zhang, Shuo
    JOURNAL OF DRUG TARGETING, 2020, 28 (05) : 500 - 507
  • [39] Outcomes associated with dual antiplatelet therapy after myocardial infarction in patients with aortic stenosis
    Martinsson, Andreas
    Li, Xinjun
    Torp-Pedersen, Christian
    Zoller, Bengt
    Andell, Pontus
    Andreasen, Charlotte
    Gislason, Gunnar
    Kober, Lars
    Sundquist, Kristina
    Smith, J. Gustav
    Andersson, Charlotte
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 281 : 140 - 145
  • [40] Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial
    Moll, Frans
    Baumgartner, Iris
    Jaff, Michael
    Nwachuku, Chuke
    Tangelder, Marco
    Ansel, Gary
    Adams, George
    Zeller, Thomas
    Rundback, John
    Grosso, Michael
    Lin, Min
    Mercur, Michele F.
    Minar, Erich
    JOURNAL OF ENDOVASCULAR THERAPY, 2018, 25 (02) : 158 - 168
12345